Allergan (AGN +0.6%) moves up a bit today after JMP Securities ups the shares to Buy on the back...

|About: Allergan plc (AGN)|By:, SA News Editor

Allergan (AGN +0.6%) moves up a bit today after JMP Securities ups the shares to Buy on the back of its Q4 results, and Stifel Nicolaus reiterated its Buy rating and raised its price target from $110 to $118. Stifel notes that 2013 guidance was actually robust, and strength can be seen in all its business lines, namely Botox with iOAB launch. Read more on AGN's earnings call here: Earnings Call Transcript.